Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus
Taken together, these data suggest that rVSV-SFTSV is a promising vaccine candidate for SFTSV and Heartland bandavirus with a favorable safety profile.
Authors
- Jonna B. Westover (ORCID: https://orcid.org/0000-0002-3642-2980)
- Philip D. Hicks (ORCID: https://orcid.org/0000-0002-1574-5692)
- Raegan J. Petch (ORCID: https://orcid.org/0000-0002-4508-4362)
- Paul F. Bates (ORCID: https://orcid.org/0000-0002-3918-5976)
- Brianne Roper (ORCID: https://orcid.org/0000-0003-0034-173X)
- Brian B. Gowen (ORCID: https://orcid.org/0000-0001-9113-2575)
- Tomaz B. Manzoni (ORCID: https://orcid.org/0000-0001-6380-5103)
Institutions
- Utah State University (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Vaccines
- Published
- 2024-12-12
- DOI
- https://doi.org/10.3390/vaccines12121403
- Citations
- 8
- Primary Topic
- Viral Infections and Vectors
- Type
- article
- Field-Weighted Citation Impact
- 3.11